Scotia Capital’s Astera Labs ALAB Stock Holding History

Scotia Capital’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,054	Closed	-$206K	–	970
2025 Q3	$206K	Buy	+1,054	New	+$173K	﹤0.01%	848

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Scotia Capital's ALAB Position: Q4 2025 in Review

Scotia Capital sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 1,054 shares — an estimated $206K sold.

Scotia Capital first reported a position in ALAB in Q3 2025 and held it in 1 quarter. The position peaked at $206K in Q3 2025. 700 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

Scotia Capital reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
Scotia Capital sold 1,054 Astera Labs shares in Q4 2025, an estimated $206K.
Scotia Capital first reported a position in Astera Labs in Q3 2025 and held it in 1 quarter.
Scotia Capital's Astera Labs position peaked at $206K in Q3 2025.
700 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Scotia Capital's 13F filing for Q4 2025, filed 12 Feb 2026.